Research Areas

Shop Popular Products

Product Categories

No categories available

FAQs

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur quis risus id enim vehicula interdum et ac sem.

  • The expected molecular weight (MW) listed in the product datasheet is based solely on the size of the target protein’s amino acid sequence. It’s important to remember that many factors can affect the banding pattern of your western blot including: (1) the existence of a splice variant, (2) the quality of the loaded sample, (3) the protein extraction method, and (4) the protein transfer conditions. To achieve accurate results, you may need to systematically adjust the protein extraction method or the protein transfer conditions.

    • If the band’s MW is below the expected MW it could be due to a splice variant with a slightly different MW.
      • Heat the samples at 70°C for 10 min.
      • Increase the transfer time.
    • If the band’s MW is above the expected MW, it could be due to post-translational modifications.
    • In either event, you should use a blocking peptide as a negative control.

  • Some toxins and peptides are soluble in DMSO; you can find this information in the product specification section. For these products, prepare a concentrated stock solution first.

    1. Centrifuge vial (10,000 x g, 5 minutes) before adding solvent.
    2. Dissolve the lyophilized reagent in DMSO. We recommend keeping a concentrated stock solution at 1-10 mM (100-1000X higher than the final working concentration).
    3. Once the peptide is completely dissolved in DMSO, slowly dilute the peptide in pure water (or buffer) to the desired final working concentration.

    Note: We recommend that you maintain a DMSO concentration as low as possible. For cell assays, a final concentration of 0.1–0.5% DMSO (v/v) is considered acceptable. For other experiments, 5% DMSO (v/v) is recommended; adjust this according to your experimental requirements.

  • FAQ 3FAQ 3FAQ 3FAQ 3

Category: Cardiac Failure
Clear
286 Results
  • α-Conotoxin GI
    Bioassay Tested
    α-Conotoxin GI
    A potent and selective antagonist of the muscle-type nicotinic acetylcholine receptor (nAChR)
    • Product Code: STC-500
    • Short Description: A potent and selective antagonist of the muscle-type nicotinic acetylcholine receptor (nAChR)
    • Applications: Electrophysiology
    • CAS No.: 76862-65-2
    • MW: 1437.6 Da
  • α-Conotoxin MI
    Bioassay Tested
    α-Conotoxin MI
    A potent antagonist of muscle α1/β1/γ/δ nicotinic acetylcholine receptors (nAChRs)
    • Product Code: STC-370
    • Short Description: A potent antagonist of muscle α1/β1/γ/δ nicotinic acetylcholine receptors (nAChRs)
    • Applications: Electrophysiology
    • CAS No.: 83481-45-2
    • MW: 1493.7 Da
  • α-Conotoxin EIIB
    Bioassay Tested
    α-Conotoxin EIIB
    A potent antagonist of muscle α1/β1/γ/δ nicotinic acetylcholine receptors (nAChRs)
    • Product Code: STC-230
    • Short Description: A potent antagonist of muscle α1/β1/γ/δ nicotinic acetylcholine receptors (nAChRs)
    • Applications: Electrophysiology
    • MW: 1754.5 Da
  • Ceratotoxin-2
    Bioassay Tested
    Ceratotoxin-2
    A potent blocker of central nervous system voltage-gated Na+ channels
    • Product Code: STC-100
    • Short Description: A potent blocker of central nervous system voltage-gated Na+ channels
    • Applications: Electrophysiology
    • MW: 4092.7 Da
  • BDS-I
    Bioassay Tested
    BDS-I
    A blocker of KV potassium channels and a modulator that slows the inactivation of NaV sodium channels (particularly NaV1.7)
    • Product Code: STB-400
    • Short Description: A blocker of KV potassium channels and a modulator that slows the inactivation of NaV sodium channels (particularly NaV1.7)
    • Applications: Electrophysiology
    • CAS No.: 207621-38-3
    • MW: 4708 Da
  • ATX-II
    Bioassay Tested
    ATX-II
    A potent activator of voltage-gated sodium NaV channels that primarily targets cardiac NaV1.5 channels by delaying their fast inactivation
    • Product Code: STA-700
    • Short Description: A potent activator of voltage-gated sodium NaV channels that primarily targets cardiac NaV1.5 channels by delaying their fast inactivation
    • Applications: Electrophysiology
    • CAS No.: 60748-45-0
    • MW: 4935 Da
  • Anthopleurin-C
    Bioassay Tested
    Anthopleurin-C
    A potent cardiotoxin that delays the inactivation of NaV channels
    • Product Code: STA-400
    • Short Description: A potent cardiotoxin that delays the inactivation of NaV channels
    • Applications: Electrophysiology
    • MW: 4877.6 Da
  • AmmTx3 Toxin
    Bioassay Tested
    AmmTx3 Toxin
    A specific blocker of KV channels (subtypes KV4.2 and KV4.3) that selectively targets native neuronal A-type K+ currents
    • Product Code: STA-305
    • Short Description: A specific blocker of KV channels (subtypes KV4.2 and KV4.3) that selectively targets native neuronal A-type K+ currents
    • Applications: Electrophysiology
    • MW: 3822 Da
  • Apamin
    Bioassay Tested
    Apamin
    A blocker of small conductance Ca2+-Activated K+ Channels (SK Type, KCa2)
    • Product Code: STA-200
    • Applications: Electrophysiology
    • CAS No.: 24345-16-2
    • MW: 2027.3 Da
  • AaH1 Toxin
    Bioassay Tested
    AaH1 Toxin
    A potent modulator of NaV channels that delays/slows fast inactivation
    • Product Code: STA-155
    • Short Description: A potent modulator of NaV channels that delays/slows fast inactivation
    • Applications: Electrophysiology
    • MW: 6804 Da
Load More Results
Loading...

Have questions about our products?

Step-by-Step Protocols